Clinical Trial Update: A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160) [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating GWP42003 for symptomatic treatment of Ulcerative Colitis has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GWP42003

Snippet

Sponsor: GW Research Ltd | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2015-08-14